MoneyWorks4Me

Zim Laboratories - Quaterly Results

30 Oct 2021 Evaluate
A decrease in the sales to Rs. 757.26 millions was observed for the quarter ended September 2021. The sales stood at Rs. 864.49 millions during the similar quarter previous year.The Total Profit for the quarter ended September 2021 of Rs. 20.02 millions grew from Rs.-0.57 millionsThe Operating Profit of the company witnessed a decrease to 95.71 millions from 113.36 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202109 202009 % Var 202109 202009 % Var 202103 202003 % Var
Sales 757.26 864.49 -12.40 1393.66 1562.21 -10.79 3036.29 2743.20 10.68
Other Income 8.87 1.68 427.98 21.38 8.12 163.30 24.49 46.56 -47.40
PBIDT 95.71 113.36 -15.57 157.51 217.09 -27.44 392.62 244.38 60.66
Interest 25.79 26.68 -3.34 51.25 56.11 -8.66 108.86 126.55 -13.98
PBDT 69.92 34.88 100.46 106.26 109.18 -2.67 231.95 117.83 96.85
Depreciation 40.65 35.43 14.73 74.29 70.98 4.66 146.14 132.71 10.12
PBT 29.27 -0.55 -5421.82 31.97 38.20 -16.31 85.81 -14.88 -676.68
TAX 9.25 0.02 46150.00 10.09 11.12 -9.26 29.64 -32.28 -191.82
Deferred Tax 4.61 -8.44 -154.62 5.24 -3.68 -242.39 29.47 -31.05 -194.91
PAT 20.02 -0.57 -3612.28 21.88 27.08 -19.20 56.17 17.40 222.82
Equity 162.42 162.42 0.00 162.42 162.42 0.00 162.42 161.81 0.38
PBIDTM(%) 12.64 13.11 -3.61 11.30 13.90 -18.67 12.93 8.91 45.15
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..